Zacks Investment Research upgraded shares of CAREFUSION CORP (CFN) from NEUTRAL to OUTPERFORM on September 11, 2012, with a target price of $29.90.
CareFusion is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. The company develops market-leading technologies including Alaris IV pumps, Pyxis automated dispensing and patient identification systems, AVEA and Pulmonetic Systems ventilation and respiratory products, ChloraPrep and MedMined services for infection prevention, neurological monitoring and diagnostic products, V. Mueller surgical instruments, and an extensive line of products that support interventional medicine. The company is headquartered in San Diego, California.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on CAREFUSION CORP (CFN),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment